Plasma interleukin 2 receptor levels in renal allograft recipients
Robert B. Colvin(Harvard University), A. Benedict Cosimi(Massachusetts General Hospital), Thomas Fuller(Harvard University), L. MacKeen(One Cell Systems (United States)), Patrick C. Kung(Columbia University Irving Medical Center), S H Ip(One Cell Systems (United States))
Cited by 129
Related Papers
The Banff 97 working classification of renal allograft pathology
|Kidney International|1999|3.1k
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
|American Journal of Transplantation|2008|1.9k
Reactivity of a monoclonal antibody with human ovarian carcinoma.
|Journal of Clinical Investigation|1981|1.7k
International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology
|Kidney International|1993|1.5k
Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
|American Journal of Transplantation|2014|1.3k